Adults with obesity receiving tirzepatide 10 mg or 15 mg may be able to maintain most of their weight loss after switching to ...

A pair of trial results published in medical journals suggest switching from high-dose injectables to lower doses or pills could help people with obesity keep their weight down over the long term.

People who stop using GLP-1s tend to regain much of the lost weight. Two new studies identify strategies that can help stave this off. Two new clinical trials suggest options for maintaining weight ...

Hers is a telehealth platform offering GLP-1 weight loss medications. Learn about its costs, pros, cons, and if it's right for you.

Explore alternatives to GLP-1 weight loss drugs if insurance won’t cover them, including appeals, discounts, other ...

We reviewed popular telehealth and pharmacy options for finding Zepbound online. Here are the top providers for safe access and ongoing support.

Millions of people with Medicare will soon be eligible to get discounted GLP-1 drugs for weight loss. Here's how it will work ...

The ⁠Food and Drug ⁠Administration proposed excluding the active ingredients in Novo Nordisk ‌and Eli Lilly's blockbuster obesity and diabetes medications from the ⁠list ⁠of drugs that outsourcing ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

Shares of HIMS climbed 7% following the announcement of Eli Lilly’s GLP-1 weight loss medications on its platform Healthcare providers can now prescribe Zepbound vials, KwikPen, and Foundayo through ...

The daily pill called Foundayo got a fast track through the Food and Drug Administration. It will compete with the pill form of Wegovy as an... The FDA approves a new obesity pill, giving patients ...

Him & Hers announced Thursday that eligible users can now access the full range of U.S. Food and Drug Administration (FDA)-approved GLP-1 medications on its platform. Providers can now send ...